Immune Response Testing Market Report 2026

Immune Response Testing Market Overview

• Immune Response Testing market size has reached to $16.36 billion in 2025 • Expected to grow to $26.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: Rising Prevalence Of Autoimmune Diseases Fueling The Growth Of The Market Due To Increasing Environmental Pollutant Exposure And Need For Early Diagnosis • Market Trend: Advancing Innovation Through Next-Generation Immune Profiling Technologies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Immune Response Testing Market?

Immune response testing is a diagnostic process that evaluates how the immune system reacts to a specific antigen, pathogen, or vaccine. It evaluates the presence, type, and strength of immune activity by detecting antibodies, immune cells, or cytokine levels in the body. This test helps to determine immunity status, diagnose immune-related conditions, and guide treatment or vaccination decisions. The main types of immune response testing are antibody testing, cytokine testing, cellular testing, and complement system testing. Antibody testing refers to a medical test that detects the presence of specific antibodies in the blood, indicating a past infection or immune response to a particular pathogen. These tests find applications in allergy testing, human immunodeficiency virus (HIV) disease, cancer, rheumatoid arthritis, systemic lupus erythematosus, and others, serving a wide range of end users, including hospitals and clinics, diagnostic laboratories, research institutes, and home care settings.

What Is The Immune Response Testing Market Growth Forecast?

The immune response testing market size is expected to see rapid growth in the next few years. It will grow to $26.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for personalized immune profiling, rising use of immune monitoring in oncology and vaccines, expansion of point-of-care immune testing, growing integration of AI in diagnostic interpretation, increasing focus on early immune dysfunction detection. Major trends in the forecast period include increasing adoption of multiplex immune assays, rising use of cellular immune response analysis, growing integration of automated testing platforms, expansion of high-sensitivity diagnostic panels, enhanced focus on immune monitoring.

Global Immune Response Testing Market Segmentation

1) By Type Of Testing: Antibody Testing, Cytokine Testing, Cellular Testing, Complement System Testing 2) By Application: Allergy Testing, Human Immunodeficiency Virus (HIV) Disease, Cancer, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Other Applications 3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings Subsegments: 1) By Antibody Testing: Immunoglobulin G (IgG) Testing, Immunoglobulin A (IgA) Testing, Immunoglobulin M (IgM) Testing, Neutralizing Antibody Testing, Rapid Antibody Testing 2) By Cytokine Testing: Enzyme-Linked Immunosorbent Assay (ELISA)-Based Cytokine Assays, Multiplex Cytokine Assays, Flow Cytometry-Based Cytokine Assays, Cytometric Bead Array, Quantitative Polymerase Chain Reaction (qPCR)-Based Cytokine Analysis 3) By Cellular Testing: T-Cell Response Assays, B-Cell Response Assays, Natural Killer (NK) Cell Assays, Lymphocyte Proliferation Assays, ELISpot Assays 4) By Complement System Testing: Total Hemolytic Complement (CH50) Assay, Alternative Pathway Hemolytic Complement (AH50) Assay, Complement Component 3 And 4 (C3 And C4) Complement Testing, Mannose-Binding Lectin (MBL) Testing, Complement Activity Assays

What Is The Driver Of The Immune Response Testing Market?

The rising prevalence of autoimmune diseases is expected to propel the growth of the immune response testing market going forward. Autoimmune diseases refer to conditions in which the body’s immune system mistakenly attacks its own healthy cells and tissues. The growing prevalence of autoimmune diseases is primarily due to an increased exposure to environmental pollutants, which can disrupt immune function and trigger immune attacks on the body’s own tissues. Immune response testing enhances autoimmune disease management by providing precise insights into the body’s immune activity, enabling early diagnosis and personalized treatment plans. It supports better disease monitoring and helps improve patient outcomes through targeted therapy adjustments. For instance, in February 2024, according to the Arthritis Australia, an Australia-based non-profit organization, it is estimated that 562,378 Australians will be living with RA in 2025, accounting for 14% of all arthritis cases that year. By 2040, this number is projected to rise by 33% to 748,721 people. This represents an increase of 186,343 Australians with RA compared with 2025. Therefore, the rising prevalence of autoimmune diseases is driving the growth of the immune response testing industry.

Key Players In The Global Immune Response Testing Market

Major companies operating in the immune response testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Quest Diagnostics Incorporated, Eurofins Scientific SE, PerkinElmer Inc., bioMérieux SA, Bruker Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., EUROIMMUN Medizinische Labor diagnostika AG, NanoString Technologies Inc., GenScript Biotech Corporation, Cell Signaling Technology Inc., Sysmex Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd., Merck KGaA

Global Immune Response Testing Market Trends and Insights

Major companies operating in the Immune Response Testing market are focusing on developing innovative solutions, such as immune profiling technologies, to meet the rising demand for advanced diagnostics in post-viral syndromes and adaptive immunity assessment. Immune profiling technologies are designed to analyze the immune system comprehensively, assessing both cellular and humoral responses, which provides more detailed insights compared to traditional serological tests that mainly detect antibody levels. For instance, in April 2024, Virax Biolabs Group Limited, a UK-based biotechnology company, launched its portfolio of immune profiling solutions at ESCMID Global 2024, targeting evaluation of adaptive immunity in post-viral conditions. These solutions combine advanced assays, including multi-parametric flow cytometry and targeted biomarker panels, enabling precise characterization of immune cell subsets and functional responses. Unique features include high sensitivity, customizable panels for various post-viral syndromes, and integration with digital reporting platforms for streamlined data interpretation. Applications range from clinical research to personalized patient monitoring, offering benefits such as early detection of immune dysfunction and support for therapeutic decision-making.

What Are Latest Mergers And Acquisitions In The Immune Response Testing Market?

In July 2024, Thermo Fisher Scientific Inc., a US-based biotech company, acquired Olink Holding AB for $3.1 billion. With this acquisition, Thermo Fisher Scientific aims to enhance its life sciences leadership by adding Olink’s advanced proteomics, speeding up research, and advancing precision medicine for better patient outcomes. Olink Holding AB is a Sweden-based biotechnology company specializing in immune response testing via protein biomarker detection.

Regional Outlook

North America was the largest region in the immune response testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Immune Response Testing Market?

The immune response testing market includes revenues earned by entities through measuring immune cell activity, antibody detection and quantification, cytokine profiling, T-cell and B-cell functional assays, allergy testing, vaccine efficacy assessment, autoimmune disease testing, infectious disease immune response analysis, and monitoring immune-related therapy effectiveness. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Immune Response Testing Market Report 2026?

The immune response testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the immune response testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.